Clinical Trial Update: Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating rivaroxaban for central line-associated thrombosis in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Central Venous Catheter Thrombosis

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: London Health Sciences Centre | Conditions: Neoplasm, Central Venous Catheter Thrombosis | Phase 4 | Status: COMPLETED